Monday, September 29, 2025

 

Indoor wood burners linked to a decline in lung function




European Respiratory Society
Dr Laura Horsfall 

image: 

Dr Laura Horsfall

view more 

Credit: Laura Horsfall/ERS




Using a wood burning stove at home can lead to a decline in lung function, according to research presented at the European Respiratory Society Congress in Amsterdam, the Netherlands [1].

The study was presented by Dr Laura Horsfall, Principal Research Fellow from the Institute of Health Informatics, University College London, UK.

The use of solid fuel for domestic heating has increased in Europe due to the marketing of wood as renewable energy and high fossil fuel prices. In the UK, the proportion of harmful PM2.5 air pollution (fine particulate matter) caused by domestic solid fuel is now 20% of the total, compared with 4% for road vehicle exhaust emissions. Annual emissions, specifically from domestic wood burning, almost doubled from 3,200 tonnes in 2009 to 6,000 tonnes in 2023.

Dr Horsfall told the Congress: “We know wood burning at home emits harmful air pollution both indoors and outdoors including known carcinogens. Despite this, air pollution from this source has approximately doubled in the UK since 2009 as more people install and use wood stoves. However, the link with health outcomes in high-income countries is not well understood and residential areas with high emissions are hard to identify using existing air quality monitoring networks.

Building on a previous study that mapped the use of solid fuel burning stoves across the UK, the researchers used data from the English Longitudinal Study of Aging (ELSA) [2] to study the connection between self-reported solid fuel use at home in England and lung function decline.

They assessed patients’ lung function according to a measure called FEV1, which quantifies the amount of air a person can forcefully exhale in the first second of a breath. Lower FEV₁ values are associated with increased risk of respiratory complications and poorer health outcomes, making FEV₁ a key objective marker in monitoring diseases like COPD and asthma.

Studying health impacts is challenging because wood-burning households tend to be wealthier and healthier overall. Dr Horsfall explained: “We found that people using solid fuel had lower rates of smoking and lung disease, which can mask the true effects of solid fuel exposure.

“However, using repeated lung function measurements over an eight-year period, we found that lung function declined faster among solid fuel users compared to non-users, even after adjusting for socioeconomic and housing factors. This suggests an important link between solid fuel use and respiratory decline, despite the healthier baseline of the exposed group.

“Our study suggests that high levels of particulate matter from stoves damage respiratory tissues, causing inflammation in a similar way to cigarette smoke,” she added.

Dr Horsfall and her team now plan to investigate whether people living in or near areas with a high concentration of wood stoves, such as the wealthier parts of London, also show increased rates of respiratory issues, such as inhaler prescriptions and hospital visits for lung conditions.

Professor Ane Johannessen, Head of the European Respiratory Society’s expert group on epidemiology and environment, based at the University of Bergen, Norway, who was not involved in the research said: "In Europe, we are seeing a growing trend for using wood-burning stoves at home. Research in other parts of the world, where traditional wood burning is used in the home, has shown that this is harmful and causes asthma, COPD and lung cancer.

"These findings suggest that wood-burners used in European homes may have similar effects and should be considered a potential environmental risk factor when assessing respiratory health, especially in patients with unexplained lung function decline or chronic respiratory symptoms. Although new eco-design European wood-burners are generally considered cleaner and safer than more traditional wood stoves, many European homes still employ older wood-burners, and even the newer stoves may not be entirely risk-free.

“This study underscores the need for clearer public health guidance and regulation around domestic wood burning. People should be aware that these stoves could be harming them and their families, and doctors should be asking their patients about whether they are using stoves at home.”

LEGALIZE DRUGS AVOID OD'S

Ketamine deaths increase twenty-fold since 2015 with mixing drugs on the rise





King's College London




Deaths due to illicit ketamine use have increased twenty-fold since 2015 – but these deaths are increasingly occurring in complex polydrug settings, raising doubts over whether single-substance drug policies can reduce harms.

Analysis by King’s College London, with the University of Hertfordshire and Manchester Metropolitan University, of coroner’s reports in England, Wales and Northern Ireland between 1999 and 2024 found there were 696 deaths with detections of illicit ketamine between 1999 and 2024.  It represents the most detailed assessment to date of ketamine-related deaths in England, Wales, and Northern Ireland.

Ketamine is a Class B anaesthetic drug that has hallucinogenic effects. It’s cheap cost – around £15-30 for a gram compared to £80 for cocaine – could be driving increased consumption say researchers.

The number of people using ketamine in England and Wales has continued to rise with an estimated 299,000 people aged 16-59 reporting illicit ketamine use in 2024. The drug has been implicated in the deaths of celebrities, including Friends actor Matthew Perry, and Elon Musk is reported to use ketamine for his moods.

Whilst annual deaths with post-mortem detections of illicit ketamine have risen over the past decade, the proportion of deaths where ketamine was the sole or primary cause has fallen, reflecting a shift towards increasingly risky patterns of polydrug use. Opioids, cocaine, benzodiazepines, and gabapentinoids were frequently co-implicated in deaths, with the average number of substances involved in each case also rising.

The study also identified a demographic shift. While harms of ketamine use among young people – such as bladder injury and dependence – remain a serious concern, deaths are increasingly occurring among older, socioeconomically disadvantaged, and dependent drug users, rather than being confined to younger recreational populations.

Dr Caroline Copeland, lead author of the study from King’s College London and the Director of the National Programme on Substance Use Mortality said: “We are seeing more ketamine-related deaths, but these deaths rarely involve ketamine alone. They are increasingly part of complex polydrug use patterns, often among people facing social disadvantage and entrenched drug dependence. This means single-drug policies, such as reclassification, are unlikely to tackle the real drivers of harm.”

The study published today in Journal of Psychopharmacology also shows 85% of the deaths between 2020 and 2024 were men. Employment status was reported for 77% of the deaths between 2020 and 2024, with 42% employed, 42% unemployed and 11% students. The demographic profile of deaths shifted towards greater deprivation from 2020 to 2024. Death was deemed accidental in 88.9% of cases with 5.9% determined as suicidal.

The authors call for a more comprehensive response to address ketamine-related harms, including: expanded drug checking services and overdose prevention schemes, better integration of ketamine users into treatment pathways, and targeted education on the risks of polydrug use.

Ketamine can be prescribed medically as a sedative and is commonly used on animals. But when ketamine is misused, it can cause serious and sometimes irrevocable damage to the bladder. Mixing ketamine – a dissociative – with depressant drugs like opioids and benzodiazepines makes it harder to judge the effect each drug is having, which can result in people taking more of each drug than intended.

Dr Caroline Copeland added: “Illicit ketamine use has moved beyond the recreational setting. To reduce deaths, we need harm reduction, treatment, and social support strategies that reflect the realities of polydrug use – not just legislative changes focused on one substance”.

‘Deaths following illicit ketamine use in England, Wales and Northern Ireland 1999-2024: An update report to inform the reclassification debate’ is published in the Journal of Psychopharmacology.

 

Hidden genetic risk could delay diabetes diagnosis for Black and Asian men




University of Exeter





A common but often undiagnosed genetic condition may be causing delays in type 2 diabetes diagnoses and increasing the risk of serious complications for thousands of Black and South Asian men in the UK - and potentially millions worldwide.

The new study is conducted by the University of Exeter, in collaboration with Queen Mary University of London (QMUL) and funded through a Wellcome Discovery Award. It has found around one in seven Black and one in 63 South Asian men in the UK carry a genetic variant known as G6PD deficiency. Men with G6PD deficiency are, on average, diagnosed with type 2 diabetes four years later than those without the gene variant. But despite this, fewer than one in 50 have been diagnosed with the condition

G6PD deficiency does not cause diabetes, but it makes the widely used HbA1c blood test - which diagnoses and monitors diabetes - appear artificially low. This can mislead doctors and patients, resulting in delayed diabetes diagnosis and treatment.

Professor Inês Barroso from the University of Exeter said: "Our findings highlight the urgent need for changes to testing practices to tackle health inequalities. Doctors and health policy makers need to be aware that the HbA1c test may not be accurate for people with G6PD deficiency and routine G6PD screening could help identify those at risk. Addressing this issue is not only crucial for medicine, but for health equity.”

G6PD deficiency is a genetic condition that affects more than 400 million people worldwide, and is especially prevalent among those with African, Asian, Middle Eastern, and Mediterranean backgrounds. It is more common in men and usually goes undetected because it rarely causes symptoms. The World Health Organization recommends routine screening for G6PD deficiency in populations where it is common, but this is not widely implemented in the UK or many other countries.

This new study, published in Diabetes Care and supported by the National Institute for Health and Care Research Exeter Biomedical Research Centre, has found men with G6PD deficiency are at a 37 per cent higher risk of developing diabetes-related microvascular complications, such as eye, kidney, and nerve damage, compared to other men with diabetes.

The HbA1c blood test is the international standard for managing type 2 diabetes and is used in 136 countries worldwide to diagnose diabetes, including being the routine test for diagnosis in the UK. However, for people with G6PD deficiency, this test may underestimate their blood sugar levels, causing significant medical delays and increasing their risk of serious complications.

Dr Veline L’Esperance, a GP and Senior Clinical Research Fellow at QMUL, said: “These findings are deeply concerning because they show how a widely used diagnostic tool may be failing communities that are already disproportionately affected by type 2 diabetes. Too many people are being left undiagnosed until it is too late to prevent serious complications. We need greater awareness among healthcare professionals and stronger policies to ensure equitable screening and diagnosis. That is why we are launching ‘Black Health Legacy’, which aims to be the largest health research programme focused on tackling diseases that disproportionately affect people from Black backgrounds. This is about saving lives and tackling long-standing inequalities in our healthcare system.”

Professor Faye Ruddock, Chair of the Caribbean and African Health Network, said: “Black communities in the UK experience health inequalities, particularly relating to type 2 diabetes. Stigma, language, and cultural differences can contribute to delayed diagnosis, while reduced physical health checks and screening opportunities in predominantly Black communities also contribute to this disparity. This study highlights important evidence that must be used to tackle these health inequalities and improve outcomes for Black communities. Preventative measures are now needed to ensure that Black people, especially men, are not underdiagnosed or diagnosed too late.”

Anna Morris, Assistant Director of Research and Co-lead for Tackling Inequities at Diabetes UK, said: “Black and South Asian people in the UK are twice as likely to be living with undiagnosed type 2 diabetes than White people and face worse health outcomes once diagnosed. These disparities are unacceptable and must be addressed to ensure equitable diabetes care for all. If our most common test to diagnose and monitor type 2 diabetes isn’t accurate for people of all ethnicities, it could seriously compound these problems and leave people without the care they deserve. Without the reliable tools they need, healthcare professionals risk missing or misdiagnosing type 2 diabetes.”

Dr Esther Mukuka, Director of Research Inclusion at the NIHR, said: "At NIHR, we are committed to ensuring research drives fairer healthcare for all. Addressing the impact of G6PD deficiency on diabetes testing is an important step towards reducing inequalities and making sure that everyone, regardless of background, benefits equally from medical advances."

The findings are based on genetic and health data from over half a million people in UK Biobank and Genes & Health studies. The research was conducted by a multidisciplinary team of clinicians and scientists, with the support of community partners, who linked the genetic data from each participant to their medical information. By doing this the team found men with the G6PD deficiency genetic variant were diagnosed at an older age compared to those without the condition. In addition, those with G6PD deficiency and diabetes also had more diabetes related complications. Researchers say further studies in more diverse populations are now needed to confirm these findings globally.

The paper ‘Undiagnosed G6PD deficiency in Black and Asian individuals is prevalent and contributes to health inequalities in type 2 diabetes diagnosis and complications’ is published in Diabetes Care.

More information about Black Health Legacy can be found at https://blackhealthlegacy.org

ENDS

 

Tiny but mighty: Groundbreaking study reveals mosses are secret carbon heroes in subtropical forests



Dr. Zhe Wang and Dr. Weikai Bao lead a China-Croatia BRI collaboration uncovering the underestimated role of forest mosses in climate change mitigation




Biochar Editorial Office, Shenyang Agricultural University

Missing biomass stock: a systematic investigation of understory bryophytes across 413 subtropical forests 

image: 

Missing biomass stock: a systematic investigation of understory bryophytes across 413 subtropical forests
 

view more 

Credit: Zhe Wang, Xin Liu, Defeng Feng, Yanqiang Jin, Xinxu Yang, Beibei Gao & Weikai Bao





In a lush revelation from the forest floor, a new study published in Carbon Research (as an Open Access Rapid Communication) shows that mosses, those quiet, green carpet-weavers beneath our feet, are climate champions in their own right. Led by Dr. Zhe Wang from the China-Croatia “Belt and Road” Joint Laboratory on Biodiversity and Ecosystem ServicesCAS Key Laboratory of Mountain Ecological Restoration and Bioresource UtilizationChengdu Institute of Biology, Chinese Academy of Sciences, and Shanghai Normal University, alongside Dr. Weikai Bao, also of the Chengdu Institute of Biology, this research flips the script on how we view forest carbon storage. Spoiler: mosses matter—big time

The Hidden Power of the Forest Floor

We’ve long celebrated trees as Earth’s lungs. But this team asked: what about the bryophytes—the mosses and liverworts blanketing the ground in forests across Sichuan Province, China?

They surveyed 413 subtropical forests, the largest study of its kind, and discovered something astonishing:

  • Bryophytes make up a full 25% (1/4) of all understory biomass
  • That’s equivalent to 1% of the aboveground tree biomass—a tiny fraction in size, but massive in significance when scaled across millions of hectares

“For decades, mosses were treated as background scenery,” says Dr. Wang. “But our data shows they’re not just decoration—they’re critical carbon players hiding in plain sight.”

Climate Champions in Cool, Coniferous Forests

Not all forests are equal when it comes to moss magic. The study found that cold temperate coniferous forests harbor the highest bryophyte biomass, thanks to their moist, shaded, and undisturbed conditions—perfect for moss to thrive. These humble plants don’t just sit there—they soak up carbon, store nutrients, and stabilize soil, all while asking for almost nothing in return. And because they grow slowly and decompose even slower, the carbon they lock away can stay put for decades.

Why This Changes Everything

Here’s the kicker: current global carbon models often ignore bryophytes entirely. This study proves that’s a mistake.

By including bryophytes in ecosystem assessments, scientists and policymakers can:

  • Build more accurate climate models
  • Improve carbon accounting for forests and conservation programs
  • Unlock low-cost, high-impact strategies for carbon neutrality

“Preserving bryophytes isn’t just about biodiversity,” says Dr. Bao. “It’s a cost-effective, nature-based solution for climate change. They’re like free carbon credits growing on the forest floor.”

A Call for Global Attention

While this study focused on subtropical China, the implications are global. The team urges more research across tropical, boreal, and temperate zones to fully map the carbon power of mosses worldwide. “This is just the beginning,” adds Dr. Wang. “With collaborations like the China-Croatia Belt and Road Joint Laboratory, we’re building a global network to study overlooked ecosystems and their vital services.”

Meet the Minds Behind the Moss

This breakthrough is a proud achievement of Chinese Academy of Sciences and Shanghai Yangtze River Delta Urban Wetland Ecosystem National Field Observation and Research Station, showcasing China’s leadership in ecological research and international scientific cooperation. Dr. Wang’s dual affiliation with Shanghai Normal University and Chengdu Institute of Biology highlights the power of cross-regional collaboration in tackling planetary challenges. So next time you walk through a forest, look down. That soft, green carpet underfoot? It’s not just pretty—it’s protecting our planet, one tiny leaf at a time. Kudos to Dr. Zhe Wang, Dr. Weikai Bao, and their team for turning over a new (mossy) leaf in climate science. Let’s stop overlooking the little things that make a big difference. The future of carbon neutrality might just be growing at our feet.

 

 

=== 

  • Title: Missing biomass stock: a systematic investigation of understory bryophytes across 413 subtropical forests
  • Keywords: Biomass; Bryophyte; Forest type; Nutrient storage
  • Citation: Wang, Z., Liu, X., Feng, D. et al. Missing biomass stock: a systematic investigation of understory bryophytes across 413 subtropical forests. Carbon Res. 4, 55 (2025). https://doi.org/10.1007/s44246-025-00224-6 

 

=== 

About Carbon Research

The journal Carbon Research is an international multidisciplinary platform for communicating advances in fundamental and applied research on natural and engineered carbonaceous materials that are associated with ecological and environmental functions, energy generation, and global change. It is a fully Open Access (OA) journal and the Article Publishing Charges (APC) are waived until Dec 31, 2025. It is dedicated to serving as an innovative, efficient and professional platform for researchers in the field of carbon functions around the world to deliver findings from this rapidly expanding field of science. The journal is currently indexed by Scopus and Ei Compendex, and as of June 2025, the dynamic CiteScore value is 15.4.

Follow us on FacebookX, and Bluesky